Motley Fool  Dec 1  Comment 
Amarin shares rocket higher in November after the company released exciting new data on Vascepa. But will it be enough to sustain the rally more than a few weeks?
Forbes  Nov 4  Comment 
Amarin Corporation (ADR) is expected to book a narrower loss than a year ago when it reports third-quarter earnings on Thursday, November 6, 2014. Analysts are expecting a loss of 13 cents per share, up from a loss of 28 cents per share a year...
SeekingAlpha  Oct 20  Comment 
By Elephant Analytics: Amarin (NASDAQ:AMRN) mentioned in an SEC filing on October 16 that it expected cash and cash equivalents to be approximately $135.4 million at the end of Q3 2014. This puts it on track to meet its target of keeping cash...



This is a test No its not

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki